(For a live blog on European stocks, type LIVE/ in an Eikon news window)
* AstraZeneca up on report vaccines trial may resume next week
* ECB expected to hold rates; focus remains on inflation
* Travel and leisure underperform among sector indexes
* Expectations for STOXX 600 earnings worsen for Q3
(Updates prices throughout, adds comments)
By Shreyashi Sanyal
Sept 9 (Reuters) - European shares bounced back on Wednesday, on the eve of the European Central Bank's policy meeting, as AstraZeneca reversed declines after a report that it may resume its COVID-19 vaccine trial next week.
AstraZeneca Plc AZN.L had to pause global trials of its experimental vaccine after an unexplained illness in a participant. But its shares rebounded from small declines earlier in the session to inch 0.5% higher after the Financial Times report. how brash the markets have been around any vaccine updates, this understanding that delays in the process aren't necessarily cause for concern is a surprising acknowledgement of nuance," said Connor Campbell, financial analyst at spread better Spreadex.
Travel and leisure stocks .SXTP were the laggards with a 0.9% fall.
The British airline easyJet EZJ.L fell 2.1%, a day after reducing its flying schedule as frequent changes in government travel restrictions hit demand.
The plane manufacturer Airbus AIR.PA fell 2% after deliveries slipped in August, slowing its recovery from a meltdown in demand induced by the coronavirus. STOXX 600 index has been stuck in a tight range since June, but investors are looking to Thursday's ECB policy meeting as a possible catalyst.
Analysts are not expecting any changes in rate policy, focusing instead on the central bank's inflation outlook and commentary on the euro's recent strength.
"We believe the ECB will try to address the downside risks to inflation and recent euro appreciation through words rather than actions at this point," wrote analysts at TD Securities.
Investors were following developments around Britain's plan for life outside the European Union's single market from Jan. 1 as the UK published legislation that it acknowledged would break a binding agreement with the EU, casting a dark shadow over the latest round of talks on a free trade agreement. for third-quarter STOXX 600 earnings have worsened, according to the latest data from Refinitiv.
Profits are now expected to fall 39.2% for the 600 companies listed on the pan-European index, against an expectation of 37.9% a week ago.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.